 Elin Grundberg
Concepts (429)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 23 | 2024 | 111 | 4.250 |
Why?
| | Polymorphism, Single Nucleotide | 42 | 2019 | 348 | 3.050 |
Why?
| | Bone Density | 22 | 2023 | 44 | 2.970 |
Why?
| | Adipose Tissue | 11 | 2022 | 27 | 2.510 |
Why?
| | Epigenesis, Genetic | 10 | 2024 | 68 | 2.340 |
Why?
| | Genome-Wide Association Study | 36 | 2024 | 184 | 2.260 |
Why?
| | Metabolic Diseases | 3 | 2020 | 12 | 2.090 |
Why?
| | Humans | 96 | 2024 | 6929 | 2.030 |
Why?
| | Gene Expression Profiling | 22 | 2024 | 125 | 2.010 |
Why?
| | Gene Expression Regulation | 17 | 2023 | 103 | 1.870 |
Why?
| | Genome, Human | 11 | 2019 | 84 | 1.770 |
Why?
| | Genetic Variation | 12 | 2017 | 166 | 1.750 |
Why?
| | Quantitative Trait Loci | 19 | 2019 | 65 | 1.710 |
Why?
| | CpG Islands | 12 | 2024 | 53 | 1.660 |
Why?
| | Female | 53 | 2024 | 3534 | 1.580 |
Why?
| | Regulatory Sequences, Nucleic Acid | 4 | 2019 | 16 | 1.530 |
Why?
| | Adult | 36 | 2023 | 1199 | 1.440 |
Why?
| | Osteoblasts | 10 | 2017 | 21 | 1.400 |
Why?
| | Middle Aged | 28 | 2024 | 645 | 1.300 |
Why?
| | Osteoporosis | 11 | 2023 | 25 | 1.290 |
Why?
| | Trophoblasts | 3 | 2023 | 15 | 1.290 |
Why?
| | Fractures, Bone | 10 | 2019 | 35 | 1.270 |
Why?
| | Diabetes Mellitus, Type 2 | 10 | 2024 | 40 | 1.180 |
Why?
| | Male | 44 | 2024 | 3367 | 1.140 |
Why?
| | Aged | 26 | 2019 | 411 | 1.050 |
Why?
| | Polymorphism, Genetic | 9 | 2021 | 100 | 1.040 |
Why?
| | Epigenomics | 4 | 2020 | 27 | 1.040 |
Why?
| | Genetic Predisposition to Disease | 16 | 2024 | 226 | 1.020 |
Why?
| | Receptors, Calcitriol | 5 | 2018 | 9 | 1.000 |
Why?
| | Genomics | 7 | 2024 | 102 | 0.940 |
Why?
| | Genotype | 21 | 2019 | 408 | 0.940 |
Why?
| | Single-Cell Analysis | 2 | 2024 | 18 | 0.940 |
Why?
| | Chromatin | 1 | 2023 | 22 | 0.900 |
Why?
| | Chromosome Mapping | 6 | 2020 | 35 | 0.900 |
Why?
| | High-Throughput Nucleotide Sequencing | 8 | 2023 | 100 | 0.890 |
Why?
| | Estrogen Receptor alpha | 4 | 2007 | 8 | 0.870 |
Why?
| | Alleles | 8 | 2017 | 213 | 0.860 |
Why?
| | Transcription Factors | 5 | 2023 | 53 | 0.810 |
Why?
| | Cardiovascular Diseases | 2 | 2019 | 49 | 0.810 |
Why?
| | Nasal Mucosa | 1 | 2021 | 8 | 0.800 |
Why?
| | Obesity | 7 | 2023 | 124 | 0.720 |
Why?
| | Phenotype | 12 | 2020 | 256 | 0.700 |
Why?
| | Aged, 80 and over | 16 | 2018 | 168 | 0.690 |
Why?
| | Gene-Environment Interaction | 3 | 2015 | 13 | 0.670 |
Why?
| | Placentation | 3 | 2023 | 15 | 0.620 |
Why?
| | Haplotypes | 7 | 2023 | 90 | 0.620 |
Why?
| | Cholesterol, HDL | 2 | 2015 | 10 | 0.620 |
Why?
| | Muscle, Skeletal | 3 | 2013 | 13 | 0.610 |
Why?
| | Triglycerides | 3 | 2023 | 22 | 0.610 |
Why?
| | Bone and Bones | 6 | 2019 | 18 | 0.610 |
Why?
| | Transcription, Genetic | 5 | 2013 | 45 | 0.580 |
Why?
| | DNA-Binding Proteins | 3 | 2011 | 40 | 0.560 |
Why?
| | Nuclear Proteins | 3 | 2012 | 52 | 0.560 |
Why?
| | Body Composition | 3 | 2005 | 27 | 0.550 |
Why?
| | Insulin Resistance | 3 | 2022 | 12 | 0.540 |
Why?
| | Sequence Analysis, DNA | 6 | 2023 | 116 | 0.510 |
Why?
| | Organ Specificity | 6 | 2017 | 23 | 0.500 |
Why?
| | Microsatellite Repeats | 2 | 2004 | 7 | 0.470 |
Why?
| | Pregnancy | 4 | 2023 | 212 | 0.470 |
Why?
| | Sweden | 11 | 2018 | 28 | 0.470 |
Why?
| | Spike Glycoprotein, Coronavirus | 3 | 2022 | 19 | 0.450 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2013 | 47 | 0.450 |
Why?
| | Animals | 13 | 2022 | 741 | 0.440 |
Why?
| | Genetic Loci | 5 | 2018 | 40 | 0.420 |
Why?
| | Hand Strength | 2 | 2018 | 7 | 0.420 |
Why?
| | Cell Lineage | 2 | 2023 | 21 | 0.420 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 2 | 2023 | 14 | 0.420 |
Why?
| | Rare Diseases | 2 | 2023 | 42 | 0.410 |
Why?
| | Membrane Proteins | 3 | 2022 | 53 | 0.390 |
Why?
| | Body Fat Distribution | 2 | 2021 | 4 | 0.370 |
Why?
| | Environmental Exposure | 1 | 2011 | 29 | 0.370 |
Why?
| | Body Mass Index | 7 | 2023 | 156 | 0.360 |
Why?
| | Child | 13 | 2024 | 3348 | 0.350 |
Why?
| | Mice | 10 | 2022 | 339 | 0.350 |
Why?
| | RNA, Messenger | 6 | 2021 | 115 | 0.350 |
Why?
| | Antibodies, Viral | 4 | 2022 | 47 | 0.340 |
Why?
| | Transcriptome | 4 | 2024 | 59 | 0.330 |
Why?
| | Gene Deletion | 2 | 2007 | 14 | 0.320 |
Why?
| | LDL-Receptor Related Proteins | 1 | 2008 | 2 | 0.320 |
Why?
| | Skin | 3 | 2013 | 16 | 0.320 |
Why?
| | Adiposity | 2 | 2023 | 10 | 0.310 |
Why?
| | Aging | 3 | 2013 | 39 | 0.310 |
Why?
| | Cohort Studies | 10 | 2015 | 281 | 0.300 |
Why?
| | Young Adult | 7 | 2021 | 641 | 0.300 |
Why?
| | 3' Untranslated Regions | 1 | 2007 | 10 | 0.300 |
Why?
| | Estradiol | 1 | 2007 | 10 | 0.290 |
Why?
| | Bone Diseases, Metabolic | 1 | 2007 | 8 | 0.290 |
Why?
| | Blood | 3 | 2015 | 10 | 0.280 |
Why?
| | Adolescent | 10 | 2024 | 2183 | 0.280 |
Why?
| | Placenta | 2 | 2023 | 23 | 0.280 |
Why?
| | Enhancer Elements, Genetic | 2 | 2017 | 19 | 0.280 |
Why?
| | Cell Differentiation | 2 | 2023 | 56 | 0.270 |
Why?
| | Osteoclasts | 2 | 2023 | 4 | 0.270 |
Why?
| | Nerve Tissue Proteins | 2 | 2023 | 25 | 0.270 |
Why?
| | Genomic Imprinting | 3 | 2011 | 8 | 0.260 |
Why?
| | Risk Factors | 10 | 2015 | 490 | 0.260 |
Why?
| | Lipoproteins | 2 | 2023 | 4 | 0.260 |
Why?
| | Linkage Disequilibrium | 5 | 2018 | 34 | 0.260 |
Why?
| | Cells, Cultured | 6 | 2015 | 84 | 0.260 |
Why?
| | Smoking | 2 | 2015 | 22 | 0.260 |
Why?
| | Dinucleotide Repeats | 1 | 2005 | 1 | 0.260 |
Why?
| | Carrier Proteins | 3 | 2022 | 35 | 0.260 |
Why?
| | Lumbar Vertebrae | 5 | 2023 | 26 | 0.250 |
Why?
| | Stem Cells | 2 | 2021 | 28 | 0.250 |
Why?
| | Adenosine | 2 | 2006 | 8 | 0.250 |
Why?
| | Accidental Falls | 2 | 2018 | 14 | 0.250 |
Why?
| | Lymphocytes | 4 | 2012 | 15 | 0.240 |
Why?
| | Eosinophilia | 1 | 2024 | 27 | 0.240 |
Why?
| | Absorptiometry, Photon | 5 | 2013 | 16 | 0.240 |
Why?
| | Gene Frequency | 7 | 2016 | 91 | 0.240 |
Why?
| | Osteoarthritis | 1 | 2023 | 3 | 0.230 |
Why?
| | Carnitine O-Palmitoyltransferase | 1 | 2023 | 1 | 0.230 |
Why?
| | Femur | 4 | 2017 | 12 | 0.220 |
Why?
| | Hyperoxia | 1 | 2022 | 5 | 0.220 |
Why?
| | Insurance Coverage | 1 | 2023 | 22 | 0.220 |
Why?
| | Genetic Association Studies | 4 | 2016 | 54 | 0.220 |
Why?
| | Glutamic Acid | 1 | 2022 | 3 | 0.210 |
Why?
| | Obesity, Abdominal | 1 | 2022 | 2 | 0.210 |
Why?
| | Viral Vaccines | 1 | 2022 | 10 | 0.210 |
Why?
| | Calcaneus | 2 | 2017 | 2 | 0.210 |
Why?
| | Gene Expression | 5 | 2022 | 67 | 0.210 |
Why?
| | Asthma | 3 | 2015 | 152 | 0.210 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 40 | 0.210 |
Why?
| | Child, Preschool | 3 | 2024 | 1562 | 0.200 |
Why?
| | Dexamethasone | 3 | 2015 | 29 | 0.200 |
Why?
| | Lipoproteins, LDL | 2 | 2023 | 4 | 0.200 |
Why?
| | Immunity, Cellular | 1 | 2021 | 18 | 0.200 |
Why?
| | Immunity, Humoral | 1 | 2021 | 14 | 0.200 |
Why?
| | Immunity, Innate | 1 | 2021 | 16 | 0.200 |
Why?
| | T-Lymphocytes | 1 | 2021 | 31 | 0.200 |
Why?
| | Hydroxysteroid Dehydrogenases | 1 | 2021 | 1 | 0.190 |
Why?
| | Abdominal Fat | 1 | 2021 | 1 | 0.190 |
Why?
| | Response Elements | 1 | 2021 | 2 | 0.190 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2019 | 41 | 0.190 |
Why?
| | Severity of Illness Index | 1 | 2021 | 148 | 0.190 |
Why?
| | Cell Line | 8 | 2013 | 79 | 0.190 |
Why?
| | Prevotella | 1 | 2020 | 1 | 0.180 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 8 | 0.180 |
Why?
| | Adipocytes | 1 | 2019 | 3 | 0.180 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2011 | 4 | 0.180 |
Why?
| | Femur Neck | 3 | 2012 | 6 | 0.180 |
Why?
| | Genetic Techniques | 1 | 2019 | 6 | 0.170 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2019 | 6 | 0.170 |
Why?
| | Mendelian Randomization Analysis | 1 | 2019 | 8 | 0.170 |
Why?
| | Folic Acid | 1 | 2019 | 17 | 0.170 |
Why?
| | Spermatozoa | 1 | 2019 | 22 | 0.170 |
Why?
| | Pericardium | 1 | 2019 | 6 | 0.170 |
Why?
| | Lipids | 1 | 2019 | 8 | 0.170 |
Why?
| | Diet, Reducing | 3 | 2023 | 5 | 0.170 |
Why?
| | Femur Head | 1 | 2018 | 1 | 0.170 |
Why?
| | Hip Fractures | 1 | 2018 | 1 | 0.170 |
Why?
| | Osteoporotic Fractures | 1 | 2018 | 1 | 0.170 |
Why?
| | Genetic Linkage | 2 | 2012 | 12 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 72 | 0.160 |
Why?
| | Twins, Monozygotic | 2 | 2015 | 7 | 0.160 |
Why?
| | Homeodomain Proteins | 2 | 2015 | 20 | 0.160 |
Why?
| | Wnt Proteins | 2 | 2015 | 10 | 0.150 |
Why?
| | Chromosomal Position Effects | 1 | 2017 | 3 | 0.150 |
Why?
| | Sulfites | 2 | 2013 | 5 | 0.140 |
Why?
| | Gene Regulatory Networks | 3 | 2012 | 15 | 0.140 |
Why?
| | Chylomicron Remnants | 1 | 2016 | 1 | 0.140 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2015 | 50 | 0.140 |
Why?
| | Rats | 3 | 2021 | 112 | 0.140 |
Why?
| | Prospective Studies | 4 | 2018 | 547 | 0.140 |
Why?
| | Twins | 2 | 2013 | 3 | 0.140 |
Why?
| | Infant | 1 | 2021 | 1449 | 0.140 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 2013 | 11 | 0.140 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2007 | 8 | 0.140 |
Why?
| | Twins, Dizygotic | 1 | 2015 | 3 | 0.140 |
Why?
| | Coronary Artery Disease | 2 | 2012 | 10 | 0.130 |
Why?
| | Osteogenesis | 1 | 2015 | 6 | 0.130 |
Why?
| | Calcification, Physiologic | 1 | 2015 | 3 | 0.130 |
Why?
| | Microtubule-Associated Proteins | 1 | 2015 | 5 | 0.130 |
Why?
| | Prednisone | 1 | 2015 | 12 | 0.130 |
Why?
| | Thyroxine | 1 | 2015 | 1 | 0.130 |
Why?
| | Synapsins | 1 | 2015 | 1 | 0.130 |
Why?
| | Thyroid Gland | 1 | 2015 | 3 | 0.130 |
Why?
| | Thyrotropin | 1 | 2015 | 3 | 0.130 |
Why?
| | Insulin | 3 | 2022 | 49 | 0.130 |
Why?
| | MicroRNAs | 1 | 2015 | 26 | 0.130 |
Why?
| | Immunoglobulin E | 1 | 2015 | 22 | 0.130 |
Why?
| | Adrenal Cortex Hormones | 1 | 2015 | 37 | 0.130 |
Why?
| | Mutation | 2 | 2021 | 213 | 0.120 |
Why?
| | Promoter Regions, Genetic | 3 | 2016 | 50 | 0.120 |
Why?
| | Models, Genetic | 2 | 2012 | 33 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2022 | 61 | 0.120 |
Why?
| | HLA-B27 Antigen | 1 | 2014 | 1 | 0.120 |
Why?
| | HMGA2 Protein | 1 | 2014 | 1 | 0.120 |
Why?
| | Mutant Chimeric Proteins | 1 | 2014 | 1 | 0.120 |
Why?
| | KCNQ1 Potassium Channel | 1 | 2014 | 1 | 0.120 |
Why?
| | Transcription Factor 7-Like 2 Protein | 1 | 2014 | 2 | 0.120 |
Why?
| | Pedigree | 4 | 2022 | 61 | 0.120 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 2 | 0.120 |
Why?
| | Polymerase Chain Reaction | 2 | 2005 | 85 | 0.120 |
Why?
| | Blood Glucose | 3 | 2022 | 59 | 0.120 |
Why?
| | DNA Mutational Analysis | 4 | 2009 | 43 | 0.120 |
Why?
| | Phosphofructokinase-1, Muscle Type | 1 | 2013 | 1 | 0.120 |
Why?
| | Hybridization, Genetic | 1 | 2013 | 3 | 0.120 |
Why?
| | Signal Transduction | 2 | 2020 | 133 | 0.120 |
Why?
| | Microfilament Proteins | 2 | 2012 | 12 | 0.120 |
Why?
| | RANK Ligand | 1 | 2013 | 1 | 0.110 |
Why?
| | Subcutaneous Fat, Abdominal | 1 | 2013 | 1 | 0.110 |
Why?
| | Dietary Proteins | 2 | 2023 | 8 | 0.110 |
Why?
| | Sex Characteristics | 1 | 2012 | 12 | 0.110 |
Why?
| | Subcutaneous Fat | 1 | 2012 | 1 | 0.110 |
Why?
| | Brain | 1 | 2013 | 79 | 0.110 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 2 | 2012 | 5 | 0.110 |
Why?
| | Integrin alpha1 | 1 | 2012 | 1 | 0.110 |
Why?
| | Longevity | 1 | 2012 | 3 | 0.110 |
Why?
| | Body Weight | 2 | 2023 | 52 | 0.100 |
Why?
| | Vaccination | 2 | 2022 | 70 | 0.100 |
Why?
| | Lupus Erythematosus, Systemic | 2 | 2009 | 16 | 0.100 |
Why?
| | Metabolism | 1 | 2011 | 1 | 0.100 |
Why?
| | Drug Industry | 1 | 2011 | 2 | 0.100 |
Why?
| | Rats, Sprague-Dawley | 2 | 2021 | 47 | 0.100 |
Why?
| | Sp Transcription Factors | 1 | 2011 | 1 | 0.100 |
Why?
| | Dehydroepiandrosterone Sulfate | 1 | 2011 | 1 | 0.100 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2011 | 6 | 0.100 |
Why?
| | Proto-Oncogene Proteins | 1 | 2011 | 17 | 0.100 |
Why?
| | Biomedical Research | 1 | 2011 | 27 | 0.100 |
Why?
| | Genes, Regulator | 1 | 2011 | 4 | 0.100 |
Why?
| | Genetic Markers | 1 | 2011 | 22 | 0.100 |
Why?
| | Dinoprostone | 1 | 2011 | 8 | 0.100 |
Why?
| | Base Sequence | 3 | 2023 | 87 | 0.090 |
Why?
| | Metabolic Networks and Pathways | 1 | 2010 | 10 | 0.090 |
Why?
| | Body Height | 1 | 2010 | 34 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2014 | 216 | 0.090 |
Why?
| | Adiponectin | 1 | 2009 | 3 | 0.090 |
Why?
| | Contractile Proteins | 1 | 2009 | 2 | 0.090 |
Why?
| | Cell Culture Techniques | 1 | 2010 | 8 | 0.090 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2009 | 3 | 0.090 |
Why?
| | Egg Proteins | 1 | 2009 | 4 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2009 | 14 | 0.090 |
Why?
| | HeLa Cells | 1 | 2009 | 17 | 0.090 |
Why?
| | Protein Isoforms | 1 | 2009 | 17 | 0.090 |
Why?
| | Principal Component Analysis | 1 | 2009 | 14 | 0.090 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 31 | 0.090 |
Why?
| | Cell Line, Tumor | 1 | 2009 | 98 | 0.080 |
Why?
| | Habits | 1 | 2008 | 1 | 0.080 |
Why?
| | Physical Fitness | 1 | 2008 | 7 | 0.080 |
Why?
| | Age Factors | 1 | 2009 | 211 | 0.080 |
Why?
| | Shoulder Dislocation | 1 | 2008 | 1 | 0.080 |
Why?
| | Posterior Cruciate Ligament | 1 | 2008 | 1 | 0.080 |
Why?
| | Soft Tissue Injuries | 1 | 2008 | 1 | 0.080 |
Why?
| | Collagen Type I | 1 | 2008 | 2 | 0.080 |
Why?
| | STAT4 Transcription Factor | 1 | 2008 | 3 | 0.080 |
Why?
| | Interferon Regulatory Factors | 1 | 2008 | 4 | 0.080 |
Why?
| | Antibodies, Antinuclear | 1 | 2008 | 4 | 0.080 |
Why?
| | Anthropometry | 1 | 2008 | 16 | 0.080 |
Why?
| | Leptin | 1 | 2008 | 4 | 0.080 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2008 | 8 | 0.080 |
Why?
| | Circadian Rhythm | 1 | 2008 | 7 | 0.080 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2008 | 8 | 0.080 |
Why?
| | Mice, Knockout | 2 | 2018 | 60 | 0.080 |
Why?
| | Transforming Growth Factor beta | 1 | 2008 | 13 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2008 | 2 | 0.080 |
Why?
| | Peptide Fragments | 1 | 2008 | 12 | 0.080 |
Why?
| | Thinness | 1 | 2008 | 8 | 0.080 |
Why?
| | Interleukin-6 | 1 | 2008 | 10 | 0.080 |
Why?
| | Cluster Analysis | 1 | 2008 | 43 | 0.080 |
Why?
| | Parathyroid Hormone | 1 | 2008 | 24 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2008 | 31 | 0.080 |
Why?
| | Fibroblast Growth Factors | 1 | 2008 | 30 | 0.080 |
Why?
| | Catechol O-Methyltransferase | 1 | 2007 | 5 | 0.080 |
Why?
| | Risk Assessment | 1 | 2008 | 136 | 0.080 |
Why?
| | Polymers | 2 | 2006 | 5 | 0.080 |
Why?
| | Phosphates | 2 | 2023 | 13 | 0.080 |
Why?
| | Hong Kong | 1 | 2007 | 2 | 0.080 |
Why?
| | Spinal Fractures | 1 | 2007 | 4 | 0.080 |
Why?
| | Allelic Imbalance | 1 | 2007 | 7 | 0.070 |
Why?
| | Pelvic Bones | 1 | 2007 | 9 | 0.070 |
Why?
| | Heterozygote | 1 | 2007 | 27 | 0.070 |
Why?
| | Homozygote | 1 | 2007 | 22 | 0.070 |
Why?
| | Kidney | 1 | 2008 | 94 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2019 | 26 | 0.070 |
Why?
| | Predictive Value of Tests | 1 | 2007 | 102 | 0.070 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2006 | 15 | 0.070 |
Why?
| | Registries | 1 | 2007 | 93 | 0.070 |
Why?
| | Meta-Analysis as Topic | 2 | 2019 | 14 | 0.070 |
Why?
| | Vitamin D | 1 | 2006 | 22 | 0.070 |
Why?
| | Longitudinal Studies | 2 | 2018 | 119 | 0.070 |
Why?
| | Diet | 2 | 2022 | 54 | 0.070 |
Why?
| | Hypertension | 1 | 2006 | 65 | 0.070 |
Why?
| | Cross-Sectional Studies | 1 | 2007 | 333 | 0.070 |
Why?
| | Bone Development | 2 | 2015 | 4 | 0.060 |
Why?
| | Random Allocation | 1 | 2004 | 6 | 0.060 |
Why?
| | Europe | 2 | 2015 | 40 | 0.060 |
Why?
| | Enteritis | 1 | 2024 | 4 | 0.060 |
Why?
| | Eosinophilic Esophagitis | 1 | 2024 | 6 | 0.060 |
Why?
| | Leukocytes, Mononuclear | 1 | 2024 | 15 | 0.060 |
Why?
| | Gastritis | 1 | 2024 | 12 | 0.060 |
Why?
| | Colitis, Ulcerative | 1 | 2024 | 13 | 0.060 |
Why?
| | Crohn Disease | 1 | 2024 | 25 | 0.060 |
Why?
| | Diabetes Complications | 1 | 2024 | 2 | 0.060 |
Why?
| | Otx Transcription Factors | 1 | 2024 | 2 | 0.060 |
Why?
| | DNA | 1 | 2004 | 44 | 0.060 |
Why?
| | Waist Circumference | 1 | 2023 | 4 | 0.060 |
Why?
| | Biomarkers | 1 | 2024 | 132 | 0.060 |
Why?
| | Extracellular Matrix Proteins | 2 | 2015 | 13 | 0.060 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2003 | 2 | 0.060 |
Why?
| | Premenopause | 1 | 2003 | 3 | 0.060 |
Why?
| | Apolipoproteins | 1 | 2023 | 5 | 0.060 |
Why?
| | Lipoproteins, VLDL | 1 | 2023 | 2 | 0.060 |
Why?
| | Ultrasonography | 1 | 2003 | 49 | 0.060 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2023 | 1 | 0.060 |
Why?
| | Diet, Fat-Restricted | 1 | 2023 | 2 | 0.060 |
Why?
| | Birth Weight | 1 | 2023 | 28 | 0.060 |
Why?
| | Metabolomics | 2 | 2014 | 16 | 0.050 |
Why?
| | Computational Biology | 2 | 2014 | 42 | 0.050 |
Why?
| | Weight Loss | 1 | 2023 | 36 | 0.050 |
Why?
| | Animals, Newborn | 1 | 2022 | 27 | 0.050 |
Why?
| | Blood Pressure | 1 | 2023 | 65 | 0.050 |
Why?
| | Histone Deacetylases | 1 | 2022 | 2 | 0.050 |
Why?
| | Adaptation, Physiological | 1 | 2022 | 4 | 0.050 |
Why?
| | Vaccines, Synthetic | 1 | 2022 | 9 | 0.050 |
Why?
| | Lung | 1 | 2022 | 66 | 0.050 |
Why?
| | Epitopes | 1 | 2022 | 20 | 0.050 |
Why?
| | Genome | 1 | 2022 | 33 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2012 | 198 | 0.050 |
Why?
| | RNA Interference | 1 | 2021 | 16 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2021 | 13 | 0.050 |
Why?
| | Linear Models | 2 | 2014 | 57 | 0.050 |
Why?
| | Endothelial Cells | 1 | 2021 | 25 | 0.050 |
Why?
| | Kruppel-Like Transcription Factors | 2 | 2011 | 6 | 0.050 |
Why?
| | Vaccine Potency | 1 | 2021 | 7 | 0.050 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2021 | 20 | 0.050 |
Why?
| | Immunoglobulin G | 1 | 2021 | 34 | 0.050 |
Why?
| | Antibodies, Neutralizing | 1 | 2021 | 31 | 0.050 |
Why?
| | Liver | 2 | 2012 | 130 | 0.050 |
Why?
| | Infant, Newborn | 1 | 2022 | 826 | 0.040 |
Why?
| | Mediastinum | 1 | 2019 | 5 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2019 | 5 | 0.040 |
Why?
| | Up-Regulation | 1 | 2019 | 25 | 0.040 |
Why?
| | Biopsy | 1 | 2019 | 63 | 0.040 |
Why?
| | Models, Biological | 1 | 2019 | 63 | 0.040 |
Why?
| | Walking | 1 | 2018 | 35 | 0.040 |
Why?
| | Glypicans | 1 | 2017 | 1 | 0.040 |
Why?
| | Osteocytes | 1 | 2017 | 3 | 0.040 |
Why?
| | Osteochondrodysplasias | 1 | 2017 | 3 | 0.040 |
Why?
| | Molecular Sequence Annotation | 1 | 2017 | 9 | 0.040 |
Why?
| | Growth Disorders | 1 | 2017 | 25 | 0.040 |
Why?
| | Exercise | 1 | 2018 | 132 | 0.040 |
Why?
| | Myocardium | 1 | 2016 | 9 | 0.040 |
Why?
| | Exome | 1 | 2015 | 37 | 0.030 |
Why?
| | Bone Diseases, Developmental | 1 | 2015 | 3 | 0.030 |
Why?
| | Tubulin | 1 | 2015 | 7 | 0.030 |
Why?
| | 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2015 | 1 | 0.030 |
Why?
| | Administration, Oral | 1 | 2015 | 58 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2015 | 7 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2015 | 8 | 0.030 |
Why?
| | Eosinophils | 1 | 2015 | 29 | 0.030 |
Why?
| | Upper Extremity | 1 | 2014 | 1 | 0.030 |
Why?
| | Lower Extremity | 1 | 2014 | 5 | 0.030 |
Why?
| | Skull | 1 | 2014 | 12 | 0.030 |
Why?
| | Germany | 1 | 2014 | 6 | 0.030 |
Why?
| | Blood Chemical Analysis | 1 | 2014 | 4 | 0.030 |
Why?
| | Data Mining | 1 | 2014 | 6 | 0.030 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 6 | 0.030 |
Why?
| | Internet | 1 | 2014 | 17 | 0.030 |
Why?
| | Aminopeptidases | 1 | 2013 | 1 | 0.030 |
Why?
| | Cation Transport Proteins | 1 | 2013 | 1 | 0.030 |
Why?
| | Age Distribution | 1 | 2013 | 32 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2013 | 27 | 0.030 |
Why?
| | Immunoprecipitation | 1 | 2012 | 2 | 0.030 |
Why?
| | Methylation | 1 | 2012 | 11 | 0.030 |
Why?
| | Cytokines | 1 | 2013 | 48 | 0.030 |
Why?
| | Genes | 1 | 2012 | 10 | 0.030 |
Why?
| | Endonucleases | 1 | 2012 | 1 | 0.030 |
Why?
| | Spectrin | 1 | 2012 | 2 | 0.030 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2012 | 2 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 130 | 0.030 |
Why?
| | Glycoproteins | 1 | 2012 | 9 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2012 | 15 | 0.030 |
Why?
| | Singapore | 1 | 2011 | 1 | 0.030 |
Why?
| | London | 1 | 2011 | 2 | 0.030 |
Why?
| | Pakistan | 1 | 2011 | 5 | 0.030 |
Why?
| | Genetics, Population | 1 | 2011 | 11 | 0.020 |
Why?
| | Renal Insufficiency | 1 | 2011 | 10 | 0.020 |
Why?
| | Venous Thromboembolism | 1 | 2011 | 10 | 0.020 |
Why?
| | Actin-Related Protein 2-3 Complex | 1 | 2011 | 1 | 0.020 |
Why?
| | Sulfotransferases | 1 | 2011 | 7 | 0.020 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 19 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 106 | 0.020 |
Why?
| | Cytochrome P-450 CYP2C9 | 1 | 2011 | 29 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2011 | 20 | 0.020 |
Why?
| | Chromosomes, Human, Pair 3 | 1 | 2010 | 2 | 0.020 |
Why?
| | Aryl Hydrocarbon Hydroxylases | 1 | 2011 | 58 | 0.020 |
Why?
| | Multifactorial Inheritance | 1 | 2010 | 10 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2010 | 90 | 0.020 |
Why?
| | Chromosomes, Human, Pair 14 | 1 | 2010 | 2 | 0.020 |
Why?
| | Filamins | 1 | 2009 | 2 | 0.020 |
Why?
| | Gene Silencing | 1 | 2010 | 13 | 0.020 |
Why?
| | Coronary Disease | 1 | 2009 | 10 | 0.020 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2009 | 6 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2009 | 13 | 0.020 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2009 | 2 | 0.020 |
Why?
| | Italy | 1 | 2009 | 3 | 0.020 |
Why?
| | Homocystinuria | 1 | 2009 | 3 | 0.020 |
Why?
| | Oxidoreductases | 1 | 2009 | 9 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 78 | 0.020 |
Why?
| | Pharmacogenetics | 1 | 2011 | 171 | 0.020 |
Why?
| | Age of Onset | 1 | 2009 | 28 | 0.020 |
Why?
| | Canada | 1 | 2009 | 34 | 0.020 |
Why?
| | Genetic Complementation Test | 1 | 2008 | 4 | 0.020 |
Why?
| | Introns | 1 | 2008 | 9 | 0.020 |
Why?
| | Exons | 1 | 2008 | 35 | 0.020 |
Why?
| | Prevalence | 1 | 2008 | 150 | 0.020 |
Why?
| | Base Pairing | 1 | 2008 | 1 | 0.020 |
Why?
| | Minisatellite Repeats | 1 | 2008 | 2 | 0.020 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2008 | 2 | 0.020 |
Why?
| | Cystatins | 1 | 2008 | 1 | 0.020 |
Why?
| | Serum Albumin | 1 | 2008 | 8 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 24 | 0.020 |
Why?
| | Cystatin C | 1 | 2008 | 11 | 0.020 |
Why?
| | Regression Analysis | 1 | 2008 | 52 | 0.020 |
Why?
| | Calcium | 1 | 2008 | 40 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2008 | 73 | 0.020 |
Why?
| | Valine | 1 | 2007 | 2 | 0.020 |
Why?
| | Methionine | 1 | 2007 | 6 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2008 | 114 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2008 | 275 | 0.020 |
Why?
| | Alternative Splicing | 1 | 2006 | 18 | 0.020 |
Why?
| | Repetitive Sequences, Amino Acid | 1 | 2006 | 2 | 0.020 |
Why?
| | Calcium, Dietary | 1 | 2006 | 7 | 0.020 |
Why?
| | DNA Primers | 1 | 2006 | 30 | 0.020 |
Why?
| | Genetic Testing | 1 | 2006 | 86 | 0.020 |
Why?
| | Cortisone | 1 | 1963 | 1 | 0.010 |
Why?
| | Histoplasma | 1 | 1963 | 3 | 0.010 |
Why?
| | Histoplasmosis | 1 | 1963 | 3 | 0.010 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|